Drug Shortage Report for TEVA-FLUOXETINE

Last updated on 2022-09-22 History
Report ID 153721
Drug Identification Number 02216590
Brand name TEVA-FLUOXETINE
Common or Proper name TEVA-FLUOXETINE 20MG CAPSULES
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) FLUOXETINE
Strength(s) 20MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-01-27
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-09-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2022-09-22 French Compare
v23 2022-09-22 English Compare
v22 2022-06-16 French Compare
v21 2022-06-16 English Compare
v20 2022-06-03 French Compare
v19 2022-06-03 English Compare
v18 2022-05-19 French Compare
v17 2022-05-19 English Compare
v16 2022-04-28 French Compare
v15 2022-04-28 English Compare
v14 2022-04-28 English Compare
v13 2022-04-21 French Compare
v12 2022-04-21 English Compare
v11 2022-04-01 French Compare
v10 2022-04-01 English Compare
v9 2022-03-03 French Compare
v8 2022-03-03 English Compare
v7 2022-02-24 French Compare
v6 2022-02-24 English Compare
v5 2022-02-17 French Compare

Showing 1 to 20 of 24